- call +1-201-465-4211
- email sales@mrinsights.biz
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
Scope of the Report:
This report studies the Enteric Disease Testing and Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Enteric Disease Testing and Therapeutic market by product type and applications/end industries.
According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases.
The global Enteric Disease Testing and Therapeutic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Enteric Disease Testing and Therapeutic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Alere
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bacterial disease
Viral disease
Parasitic diseases
Market Segment by Applications, can be divided into
Hospital
Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Enteric Disease Testing and Therapeutic Market Overview
1.1 Product Overview and Scope of Enteric Disease Testing and Therapeutic
1.2 Classification of Enteric Disease Testing and Therapeutic by Types
1.2.1 Global Enteric Disease Testing and Therapeutic Revenue Comparison by Types (2017-2023)
1.2.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Types in 2017
1.2.3 Bacterial disease
1.2.4 Viral disease
1.2.5 Parasitic diseases
1.3 Global Enteric Disease Testing and Therapeutic Market by Application
1.3.1 Global Enteric Disease Testing and Therapeutic Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Research
1.4 Global Enteric Disease Testing and Therapeutic Market by Regions
1.4.1 Global Enteric Disease Testing and Therapeutic Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Enteric Disease Testing and Therapeutic Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Enteric Disease Testing and Therapeutic Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Enteric Disease Testing and Therapeutic Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Enteric Disease Testing and Therapeutic Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Enteric Disease Testing and Therapeutic Status and Prospect (2013-2023)
1.5 Global Market Size of Enteric Disease Testing and Therapeutic (2013-2023)
2 Manufacturers Profiles
2.1 Alere
2.1.1 Business Overview
2.1.2 Enteric Disease Testing and Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alere Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Enteric Disease Testing and Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.3 Becton Dickinson
2.3.1 Business Overview
2.3.2 Enteric Disease Testing and Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.4 bioMérieux
2.4.1 Business Overview
2.4.2 Enteric Disease Testing and Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 bioMérieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Enteric Disease Testing and Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer Pharma
2.6.1 Business Overview
2.6.2 Enteric Disease Testing and Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bio-Rad
2.7.1 Business Overview
2.7.2 Enteric Disease Testing and Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.8 Quest Diagnostics
2.8.1 Business Overview
2.8.2 Enteric Disease Testing and Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.9 Trinity Biotech
2.9.1 Business Overview
2.9.2 Enteric Disease Testing and Therapeutic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
3 Global Enteric Disease Testing and Therapeutic Market Competition, by Players
3.1 Global Enteric Disease Testing and Therapeutic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Enteric Disease Testing and Therapeutic Players Market Share
3.2.2 Top 10 Enteric Disease Testing and Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global Enteric Disease Testing and Therapeutic Market Size by Regions
4.1 Global Enteric Disease Testing and Therapeutic Revenue and Market Share by Regions
4.2 North America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
4.3 Europe Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
4.5 South America Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
5 North America Enteric Disease Testing and Therapeutic Revenue by Countries
5.1 North America Enteric Disease Testing and Therapeutic Revenue by Countries (2013-2018)
5.2 USA Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
5.3 Canada Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
5.4 Mexico Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
6 Europe Enteric Disease Testing and Therapeutic Revenue by Countries
6.1 Europe Enteric Disease Testing and Therapeutic Revenue by Countries (2013-2018)
6.2 Germany Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
6.3 UK Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
6.4 France Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
6.5 Russia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
6.6 Italy Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Countries
7.1 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Countries (2013-2018)
7.2 China Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
7.3 Japan Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
7.4 Korea Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
7.5 India Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
8 South America Enteric Disease Testing and Therapeutic Revenue by Countries
8.1 South America Enteric Disease Testing and Therapeutic Revenue by Countries (2013-2018)
8.2 Brazil Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
8.3 Argentina Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
8.4 Colombia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Enteric Disease Testing and Therapeutic by Countries
9.1 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
9.3 UAE Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
9.4 Egypt Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
9.6 South Africa Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2013-2018)
10 Global Enteric Disease Testing and Therapeutic Market Segment by Type
10.1 Global Enteric Disease Testing and Therapeutic Revenue and Market Share by Type (2013-2018)
10.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Type (2018-2023)
10.3 Bacterial disease Revenue Growth Rate (2013-2023)
10.4 Viral disease Revenue Growth Rate (2013-2023)
10.5 Parasitic diseases Revenue Growth Rate (2013-2023)
11 Global Enteric Disease Testing and Therapeutic Market Segment by Application
11.1 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2013-2018)
11.2 Enteric Disease Testing and Therapeutic Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global Enteric Disease Testing and Therapeutic Market Size Forecast (2018-2023)
12.1 Global Enteric Disease Testing and Therapeutic Market Size Forecast (2018-2023)
12.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Regions (2018-2023)
12.3 North America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2018-2023)
12.4 Europe Enteric Disease Testing and Therapeutic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Forecast (2018-2023)
12.6 South America Enteric Disease Testing and Therapeutic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Enteric Disease Testing and Therapeutic Picture
Table Product Specifications of Enteric Disease Testing and Therapeutic
Table Global Enteric Disease Testing and Ther
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
